[Ginkgo extract EGb 761 (tenobin)/HAES versus naftidrofuryl (Dusodril)/HAES. A randomized study of therapy of sudden deafness].

Hoffmann, F; Beck, C; Schutz, A; Offermann, P

[Ginkgo extract EGb 761 (tenobin)/HAES versus naftidrofuryl (Dusodril)/HAES. A randomized study of therapy of sudden deafness]. / Ginkgoextrakt EGb 761 (Tebonin)/HAES versus Naftidrofuryl (Dusodril)/HAES. Eine randomisierte Studie zur Hörsturztherapie.

Hoffmann, F; Beck, C; Schutz, A; Offermann, P.

Affiliation

Hoffmann F; Universitäts-HNO-Klinik Freiburg im Breisgau.

Laryngorhinootologie ; 73(3): 149-52, 1994 Mar.

Article in De | MEDLINE | ID: mdl-7513516

Subject(s)

Flavonoids/administration & dosage; Hearing Loss, Sudden/drug therapy; Hydroxyethyl Starch Derivatives/administration & dosage; Nafronyl/administration & dosage; Plant Extracts; Adult; Aged; Aged, 80 and over; Female; Flavonoids/adverse effects; Ginkgo biloba; Hearing Loss, Sudden/etiology; Humans; Hydroxyethyl Starch Derivatives/adverse effects; Male; Middle Aged; Nafronyl/adverse effects; Tinnitus/drug therapy; Tinnitus/etiology

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Therapeutic Methods and Therapies TCIM: Terapias_biologicas Main subject: Flavonoids / Plant Extracts / Hydroxyethyl Starch Derivatives / Hearing Loss, Sudden / Nafronyl Type of study: Clinical_trials / Etiology_studies Language: De Journal: Laryngorhinootologie Year: 1994 Type: Article

Search on Google

Add to My VHL

XML

PubMed Links